Statera Biopharma, Inc. Amortization of Intangible Assets
Statera Biopharma, Inc. reported Amortization of Intangible Assets of $341.13 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2022-11-14
- Statera Biopharma, Inc. amortization of intangible assets for the quarter ending 2022-09-30 was $113.71K, a 15.16% decline year-over-year.
- Statera Biopharma, Inc. amortization of intangible assets for the quarter ending 2022-06-30 was $113.71K.
- Statera Biopharma, Inc. amortization of intangible assets for the quarter ending 2022-03-31 was $113.71K.
- Statera Biopharma, Inc. amortization of intangible assets for the quarter ending 2021-12-31 was $99.10K.
- Statera Biopharma, Inc. amortization of intangible assets for fiscal 2021 was $233.12K.
- Statera Biopharma, Inc. amortization of intangible assets for fiscal 2020 was $0.00.
- Statera Biopharma, Inc. amortization of intangible assets for fiscal 2011 was $13.15K, a 26.35% decline from fiscal 2010.
- Statera Biopharma, Inc. amortization of intangible assets for fiscal 2010 was $17.85K, a 290.16% increase from fiscal 2009.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 8 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $113.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $227.42K derived: sum of 2 quarters · filed 2022-11-14 | $341.13K 10-Q · filed 2022-11-14 | $440.23K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-06-30 | $113.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-28 | $227.42K 10-Q · filed 2022-10-28 | $326.52K derived: sum of 3 quarters · filed 2022-10-28 | $460.54K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-03-31 | $113.71K 10-Q · filed 2022-10-21 | $212.81K derived: sum of 2 quarters · filed 2022-10-21 | $346.83K derived: sum of 3 quarters · filed 2022-11-14 | $346.83K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-12-31 | $99.10K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $233.12K derived: sum of 2 quarters · filed 2022-11-14 | $233.12K derived: sum of 3 quarters · filed 2022-11-14 | $233.12K 10-K · filed 2022-10-06 | |
| 2021-09-30 | $134.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $134.02K derived: sum of 2 quarters · filed 2022-11-14 | $134.02K 10-Q · filed 2021-11-15 | $134.02K 10-Q · filed 2022-11-14 | $134.02K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-28 | $0.00 10-Q · filed 2022-10-28 | $0.00 derived: sum of 3 quarters · filed 2022-10-28 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-10-21 | $0.00 derived: sum of 2 quarters · filed 2022-10-21 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $0.00 10-K · filed 2022-10-06 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | ||||
| 2011-12-31 | $13.15K 10-K · filed 2012-03-13 | ||||
| 2010-12-31 | $17.85K 10-K · filed 2012-03-13 | ||||
| 2009-12-31 | $4.58K 10-K · filed 2012-03-13 |